CD4 and cancer: This is contrasted by findings reported by Demehri et al. in a murine model: TSLP-stimulated CD4+ Th2 cells were found to be key mediators of the antitumor immune response that blocks early stages of both breast and pancreatic cancer development, protecting the animals from advanced cancer and metastasis.